The streak of positive phase 3 trial results for the novel “twincretin” tirzepatide when treating patients with type 2 diabetes
Questions Remain as More ‘Twincretin’ Data in Diabetes Published
Home »
FDA OKs Extended-Release Exenatide for Children With T2D
The Food and Drug Administration has approved exenatide extended release (Bydureon/Bydureon BCise, AstraZeneca) for use in children with type 2
Diabetes Could Be Main Factor Behind Accelerated Progression of COVID-19
NEW YORK (Reuters Health) – Diabetes appears to be the primary factor for accelerated progression of COVID-19, according to a
Viennese scientists awarded grant to find ways for improving and personalizing dialysis care
Patients with malfunctioning kidneys often need dialysis to rid their blood of unwanted molecules and excess water. Personalizing the settings
Heartburn Drugs Improve Blood Sugar Control in Diabetes
WASHINGTON—Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in
Sotagliflozin Use in Diabetes Tied to Survival After Discharge
Patients with type 2 diabetes who were hospitalized for worsening heart failure and who received sotagliflozin remained alive and out
Wearable Continuous Ketone Monitoring Appears Feasible
Continuous measurement of ketone levels with a wearable device is feasible, new research suggests. A small sensing device worn on